Portfolio company
Olink Proteomics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops protein biomarker analysis platforms and immunoassay panels for pharmaceutical firms and academic researchers to support drug discovery and disease research.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alamar Biosciences
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Quanterix
This company develops ultra-sensitive biomarker detection platforms and assay kits for pharmaceutical companies, academic institutions, and clinical laboratories.
Range Biotechnologies
This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.
Somalogic
This company provides proteomic analysis services and protein measurement platforms to academic medical centres, pharmaceutical companies and biotechnology organisations for life sciences research.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Nautilus Biotechnology
This company develops a single-molecule proteomics platform for pharmaceutical firms and academic researchers to quantify and analyse the human proteome.
Ohmx.Bio
This company provides sequencing and multi-omics research services for biotechnology, pharmaceutical and clinical research organisations to support drug discovery and diagnostics development.
